D.E. Shaw & Co’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
2019
Q3
$40K Sell
2019
Q2
$314K Sell
2019
Q1
$1.27M Buy
2018
Q4
$1.23M Buy
2018
Q2
Sell
2018
Q1
$352K Sell
2017
Q4
$545K Sell
2017
Q3
$669K Buy
2017
Q2
$159K Sell
2017
Q1
$506K Sell
2016
Q4
$407K Buy
2016
Q3
$580K Buy
2016
Q2
$91K Sell
2016
Q1
$96K Buy
2015
Q3
Sell
2015
Q2
$279K Buy